Copyright Reports & Markets. All rights reserved.

Global Diagnostic Nuclear Medicines Sales Market Report 2021

Request for Sample of this report
Buy now

1 Diagnostic Nuclear Medicines Market Overview

  • 1.1 Diagnostic Nuclear Medicines Product Scope
  • 1.2 Diagnostic Nuclear Medicines Segment by Type
    • 1.2.1 Global Diagnostic Nuclear Medicines Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Tc-99m
    • 1.2.3 F-18
    • 1.2.4 Other
  • 1.3 Diagnostic Nuclear Medicines Segment by Application
    • 1.3.1 Global Diagnostic Nuclear Medicines Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Oncology
    • 1.3.3 Cardiology
    • 1.3.4 Other
  • 1.4 Diagnostic Nuclear Medicines Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Diagnostic Nuclear Medicines Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Diagnostic Nuclear Medicines Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Diagnostic Nuclear Medicines Price Trends (2016-2027)

2 Diagnostic Nuclear Medicines Estimates and Forecasts by Region

  • 2.1 Global Diagnostic Nuclear Medicines Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Diagnostic Nuclear Medicines Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Diagnostic Nuclear Medicines Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2016-2021)
  • 2.3 Global Diagnostic Nuclear Medicines Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Diagnostic Nuclear Medicines Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Diagnostic Nuclear Medicines Estimates and Projections (2016-2027)
    • 2.4.2 Europe Diagnostic Nuclear Medicines Estimates and Projections (2016-2027)
    • 2.4.3 China Diagnostic Nuclear Medicines Estimates and Projections (2016-2027)
    • 2.4.4 Japan Diagnostic Nuclear Medicines Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Diagnostic Nuclear Medicines Estimates and Projections (2016-2027)
    • 2.4.6 India Diagnostic Nuclear Medicines Estimates and Projections (2016-2027)

3 Global Diagnostic Nuclear Medicines Competition Landscape by Players

  • 3.1 Global Top Diagnostic Nuclear Medicines Players by Sales (2016-2021)
  • 3.2 Global Top Diagnostic Nuclear Medicines Players by Revenue (2016-2021)
  • 3.3 Global Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diagnostic Nuclear Medicines as of 2020)
  • 3.4 Global Diagnostic Nuclear Medicines Average Price by Company (2016-2021)
  • 3.5 Manufacturers Diagnostic Nuclear Medicines Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Diagnostic Nuclear Medicines Market Size by Type

  • 4.1 Global Diagnostic Nuclear Medicines Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Diagnostic Nuclear Medicines Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Diagnostic Nuclear Medicines Price by Type (2016-2021)
  • 4.2 Global Diagnostic Nuclear Medicines Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Diagnostic Nuclear Medicines Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Diagnostic Nuclear Medicines Price Forecast by Type (2022-2027)

5 Global Diagnostic Nuclear Medicines Market Size by Application

  • 5.1 Global Diagnostic Nuclear Medicines Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Diagnostic Nuclear Medicines Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Diagnostic Nuclear Medicines Price by Application (2016-2021)
  • 5.2 Global Diagnostic Nuclear Medicines Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Diagnostic Nuclear Medicines Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Diagnostic Nuclear Medicines Price Forecast by Application (2022-2027)

6 North America Diagnostic Nuclear Medicines Market Facts & Figures

  • 6.1 North America Diagnostic Nuclear Medicines Sales by Company
    • 6.1.1 North America Diagnostic Nuclear Medicines Sales by Company (2016-2021)
    • 6.1.2 North America Diagnostic Nuclear Medicines Revenue by Company (2016-2021)
  • 6.2 North America Diagnostic Nuclear Medicines Sales Breakdown by Type
    • 6.2.1 North America Diagnostic Nuclear Medicines Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Diagnostic Nuclear Medicines Sales Breakdown by Type (2022-2027)
  • 6.3 North America Diagnostic Nuclear Medicines Sales Breakdown by Application
    • 6.3.1 North America Diagnostic Nuclear Medicines Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Diagnostic Nuclear Medicines Sales Breakdown by Application (2022-2027)

7 Europe Diagnostic Nuclear Medicines Market Facts & Figures

  • 7.1 Europe Diagnostic Nuclear Medicines Sales by Company
    • 7.1.1 Europe Diagnostic Nuclear Medicines Sales by Company (2016-2021)
    • 7.1.2 Europe Diagnostic Nuclear Medicines Revenue by Company (2016-2021)
  • 7.2 Europe Diagnostic Nuclear Medicines Sales Breakdown by Type
    • 7.2.1 Europe Diagnostic Nuclear Medicines Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Diagnostic Nuclear Medicines Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Diagnostic Nuclear Medicines Sales Breakdown by Application
    • 7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)

8 China Diagnostic Nuclear Medicines Market Facts & Figures

  • 8.1 China Diagnostic Nuclear Medicines Sales by Company
    • 8.1.1 China Diagnostic Nuclear Medicines Sales by Company (2016-2021)
    • 8.1.2 China Diagnostic Nuclear Medicines Revenue by Company (2016-2021)
  • 8.2 China Diagnostic Nuclear Medicines Sales Breakdown by Type
    • 8.2.1 China Diagnostic Nuclear Medicines Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Diagnostic Nuclear Medicines Sales Breakdown by Type (2022-2027)
  • 8.3 China Diagnostic Nuclear Medicines Sales Breakdown by Application
    • 8.3.1 China 313 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 313 Sales Breakdown by Application (2022-2027)

9 Japan Diagnostic Nuclear Medicines Market Facts & Figures

  • 9.1 Japan Diagnostic Nuclear Medicines Sales by Company
    • 9.1.1 Japan Diagnostic Nuclear Medicines Sales by Company (2016-2021)
    • 9.1.2 Japan Diagnostic Nuclear Medicines Revenue by Company (2016-2021)
  • 9.2 Japan Diagnostic Nuclear Medicines Sales Breakdown by Type
    • 9.2.1 Japan Diagnostic Nuclear Medicines Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Diagnostic Nuclear Medicines Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Diagnostic Nuclear Medicines Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Diagnostic Nuclear Medicines Market Facts & Figures

  • 10.1 Southeast Asia Diagnostic Nuclear Medicines Sales by Company
    • 10.1.1 Southeast Asia Diagnostic Nuclear Medicines Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Diagnostic Nuclear Medicines Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Diagnostic Nuclear Medicines Sales Breakdown by Type
    • 10.2.1 Southeast Asia Diagnostic Nuclear Medicines Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Diagnostic Nuclear Medicines Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Diagnostic Nuclear Medicines Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Diagnostic Nuclear Medicines Market Facts & Figures

  • 11.1 India Diagnostic Nuclear Medicines Sales by Company
    • 11.1.1 India Diagnostic Nuclear Medicines Sales by Company (2016-2021)
    • 11.1.2 India Diagnostic Nuclear Medicines Revenue by Company (2016-2021)
  • 11.2 India Diagnostic Nuclear Medicines Sales Breakdown by Type
    • 11.2.1 India Diagnostic Nuclear Medicines Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Diagnostic Nuclear Medicines Sales Breakdown by Type (2022-2027)
  • 11.3 India Diagnostic Nuclear Medicines Sales Breakdown by Application
    • 11.3.1 India Diagnostic Nuclear Medicines Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Diagnostic Nuclear Medicines Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Diagnostic Nuclear Medicines Business

  • 12.1 Bracco Imaging
    • 12.1.1 Bracco Imaging Corporation Information
    • 12.1.2 Bracco Imaging Business Overview
    • 12.1.3 Bracco Imaging Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Bracco Imaging Diagnostic Nuclear Medicines Products Offered
    • 12.1.5 Bracco Imaging Recent Development
  • 12.2 Bayer
    • 12.2.1 Bayer Corporation Information
    • 12.2.2 Bayer Business Overview
    • 12.2.3 Bayer Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Bayer Diagnostic Nuclear Medicines Products Offered
    • 12.2.5 Bayer Recent Development
  • 12.3 Curium Pharmaceuticals
    • 12.3.1 Curium Pharmaceuticals Corporation Information
    • 12.3.2 Curium Pharmaceuticals Business Overview
    • 12.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Curium Pharmaceuticals Diagnostic Nuclear Medicines Products Offered
    • 12.3.5 Curium Pharmaceuticals Recent Development
  • 12.4 Nordion
    • 12.4.1 Nordion Corporation Information
    • 12.4.2 Nordion Business Overview
    • 12.4.3 Nordion Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Nordion Diagnostic Nuclear Medicines Products Offered
    • 12.4.5 Nordion Recent Development
  • 12.5 Triad Isotopes
    • 12.5.1 Triad Isotopes Corporation Information
    • 12.5.2 Triad Isotopes Business Overview
    • 12.5.3 Triad Isotopes Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Triad Isotopes Diagnostic Nuclear Medicines Products Offered
    • 12.5.5 Triad Isotopes Recent Development
  • 12.6 Lantheus
    • 12.6.1 Lantheus Corporation Information
    • 12.6.2 Lantheus Business Overview
    • 12.6.3 Lantheus Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Lantheus Diagnostic Nuclear Medicines Products Offered
    • 12.6.5 Lantheus Recent Development
  • 12.7 GE Healthcare
    • 12.7.1 GE Healthcare Corporation Information
    • 12.7.2 GE Healthcare Business Overview
    • 12.7.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 GE Healthcare Diagnostic Nuclear Medicines Products Offered
    • 12.7.5 GE Healthcare Recent Development
  • 12.8 China Isotope & Radiation
    • 12.8.1 China Isotope & Radiation Corporation Information
    • 12.8.2 China Isotope & Radiation Business Overview
    • 12.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Products Offered
    • 12.8.5 China Isotope & Radiation Recent Development
  • 12.9 Jubilant Pharma
    • 12.9.1 Jubilant Pharma Corporation Information
    • 12.9.2 Jubilant Pharma Business Overview
    • 12.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Jubilant Pharma Diagnostic Nuclear Medicines Products Offered
    • 12.9.5 Jubilant Pharma Recent Development
  • 12.10 Eli Lilly
    • 12.10.1 Eli Lilly Corporation Information
    • 12.10.2 Eli Lilly Business Overview
    • 12.10.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Eli Lilly Diagnostic Nuclear Medicines Products Offered
    • 12.10.5 Eli Lilly Recent Development
  • 12.11 Novartis
    • 12.11.1 Novartis Corporation Information
    • 12.11.2 Novartis Business Overview
    • 12.11.3 Novartis Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Novartis Diagnostic Nuclear Medicines Products Offered
    • 12.11.5 Novartis Recent Development
  • 12.12 SIEMENS
    • 12.12.1 SIEMENS Corporation Information
    • 12.12.2 SIEMENS Business Overview
    • 12.12.3 SIEMENS Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 SIEMENS Diagnostic Nuclear Medicines Products Offered
    • 12.12.5 SIEMENS Recent Development
  • 12.13 Dongcheng
    • 12.13.1 Dongcheng Corporation Information
    • 12.13.2 Dongcheng Business Overview
    • 12.13.3 Dongcheng Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Dongcheng Diagnostic Nuclear Medicines Products Offered
    • 12.13.5 Dongcheng Recent Development
  • 12.14 Navidea
    • 12.14.1 Navidea Corporation Information
    • 12.14.2 Navidea Business Overview
    • 12.14.3 Navidea Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Navidea Diagnostic Nuclear Medicines Products Offered
    • 12.14.5 Navidea Recent Development

13 Diagnostic Nuclear Medicines Manufacturing Cost Analysis

  • 13.1 Diagnostic Nuclear Medicines Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Diagnostic Nuclear Medicines
  • 13.4 Diagnostic Nuclear Medicines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Diagnostic Nuclear Medicines Distributors List
  • 14.3 Diagnostic Nuclear Medicines Customers

15 Market Dynamics

  • 15.1 Diagnostic Nuclear Medicines Market Trends
  • 15.2 Diagnostic Nuclear Medicines Drivers
  • 15.3 Diagnostic Nuclear Medicines Market Challenges
  • 15.4 Diagnostic Nuclear Medicines Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Diagnostic Nuclear Medicines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Nuclear Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Tc-99m
    F-18
    Other

    Segment by Application
    Oncology
    Cardiology
    Other

    The Diagnostic Nuclear Medicines market is analysed and market size information is provided by regions (countries). Segment by Application, the Diagnostic Nuclear Medicines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Bracco Imaging
    Bayer
    Curium Pharmaceuticals
    Nordion
    Triad Isotopes
    Lantheus
    GE Healthcare
    China Isotope & Radiation
    Jubilant Pharma
    Eli Lilly
    Novartis
    SIEMENS
    Dongcheng
    Navidea

    Buy now